Skip to main content

Advertisement

Log in

Use of antibodies recognizing cyclic citrullinated peptide in the differential diagnosis of joint involvement in systemic sclerosis

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

Objective: To determine the prevalence of anti-cyclic citrullinated peptide (CCP) antibodies in systemic sclerosis (SSc) and to assess any association between the presence of anti-CCP, radiographic features, and clinical manifestations. Materials and methods: Anti-CCP antibodies and rheumatoid factor (RF) were tested in serum samples from 75 patients with SSc (64 women and 11 men), with a mean age of 59.4 years (range 24–85) with either diffuse (dcSSc) and limited (lcSSc) cutaneous involvement. As a control group, 22 age- and sex-matched healthy controls (HCs) were examined. Standard radiographs of the hands and wrists were examined in each patient. Results: The presence of anti-CCP was found in sera of 10.6% (8/75) patients with SSc (lcSSc 3 of 44, 6.8%; dcSSc 5 of 31, 16.1%). None of the HCs was positive for anti-CCP. The positivity of RF was observed in 19 of 75 (25.3%) SSc patients (lcSSc 10 of 44, 22.7%; dcSSc 9 of 31, 29%). Statistically significant association was found between anti-CCP positivity and the presence of arthritis (p<0.0001) and marginal erosions (p=0.001). Conclusion: Our data show that joint involvement is a common presenting feature of SSc. In this report, we show that anti-CCP antibodies can be detected also in patients with SSc, but they are generally less commonly present than in adults with rheumatoid arthritis (RA). Thus, the finding of high titers of anti-CCP antibodies may help to define the diagnosis of overlap syndrome SSc/RA and facilitate diagnosis and appropriate treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Medsger TA (1979) Progressive systemic sclerosis: skeletal muscle involvement. Clin Rheum Dis 5(1):103–113

    Google Scholar 

  2. Blocka KLN, Basset LW, Furst DE, Clements PJ, Paulus HE (1981) The arthropathy of advanced progressive systemic sclerosis. A radiographic survey. Arthritis Rheum 24(7):874–884

    Article  PubMed  CAS  Google Scholar 

  3. Misra R, Darton K, Jewkes RF, Black CM, Maini RN (1995) Arthritis in scleroderma. Br J Rheumatol 34:831–837

    Article  PubMed  CAS  Google Scholar 

  4. La Montagna G, Sodano A, Capurro V, Malesci D, Valentini G (2005) The arthropathy of systemic sclerosis: a 12 month prospective clinical and imaging study. Skeletal Radiol 34(1):35–41

    Article  PubMed  Google Scholar 

  5. Lovell CR, Jayson MIV (1979) Joint involvement in systemic sclerosis. Scand J Rheumatol 8:154–160

    PubMed  CAS  Google Scholar 

  6. Zimmermann C, Steiner G, Skriner K, Hassfeld W, Petera P, Smolen JS (1998) The concurrence of rheumatoid arthritis and limited systemic sclerosis. Arthritis Rheum 41(11):1938–1945

    Article  PubMed  CAS  Google Scholar 

  7. Schellekens GA, Visser H, De Jong BAW, van de Hoogen FHJ, Hazes JMW, Breedveld FC et al (2000) The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum 43(1):155–163

    Article  PubMed  CAS  Google Scholar 

  8. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee (1980) Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 23:581–590

    Article  Google Scholar 

  9. LeRoy EC, Black CM, Fleischmajer R et al (1988) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15:202–205

    PubMed  CAS  Google Scholar 

  10. Ferri C, Valentini G, Cozzi F, Sebastiani M, Michelassi C, La Montagna G et al (2002) Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients. Medicine (Baltimore) 81:139–153

    Article  Google Scholar 

  11. Clements PJ, Lachenbruch PA, Seibold J et al (1955) Intra- and interobserver variability of total skin thickness score (modified Rodnan) in systemic sclerosis (SSc). J Rheumatol 22:1281–1285

    Google Scholar 

  12. Horiki T, Moriuchi J, Takaya M, Uchiyama M, Hoshina Y, Inada K et al (1996) The coexistence of systemic sclerosis and rheumatoid arthritis in five patients. Arthritis Rheum 39(1):152–156

    Article  PubMed  CAS  Google Scholar 

  13. Baron M, Srolovitz H, Lander P, Kapusta M (1982) The coexistence of rheumatoid arthritis and scleroderma: a case report and review of the literature. J Rheumatol 9(6):947–950

    PubMed  CAS  Google Scholar 

  14. Cohen MJ, Persellin RH (1982) Coexistence of rheumatoid arthritis and systemic sclerosis in four patients. Scand J Rheumatol 11(4):241–245

    PubMed  CAS  Google Scholar 

  15. Armstrong RD, Gibson T (1982) Scleroderma and erosive polyarthritis: a disease entity? Ann Rheum Dis 41:141–146

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Francesca Ingegnoli.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ingegnoli, F., Galbiati, V., Zeni, S. et al. Use of antibodies recognizing cyclic citrullinated peptide in the differential diagnosis of joint involvement in systemic sclerosis. Clin Rheumatol 26, 510–514 (2007). https://doi.org/10.1007/s10067-006-0313-3

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-006-0313-3

Keywords

Navigation